Projects funded by the NCN
Development of novel potential therapeutics in inflammatory bowel diseases based on nanoformulations employing senomodulators
2024/53/B/NZ7/01313
Keywords:
Inflammatory bowel diseases colitis senescence nanocomplexes phospholipase A2 enzyme family
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ5_7: Human disease treatment
- NZ7_16: Other related subjects
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Principal investigator (from the host institution):
Number of co-investigators in the project: 12
Call: OPUS 27 - announced on 2024-03-21
Amount awarded: 3 541 628 PLN
Project start date (Y-m-d): 2025-02-17
Project end date (Y-m-d): 2029-02-16
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.